Concepedia

Hyeryun Kim

HK

26

Publications

2.7K

Citations

18

H-Index

2009

Active since

Affiliations

Agios Pharmaceuticals (United States)(Current)

Yonsei University

Sungkyunkwan University

Samsung Medical Center

Asan Medical Center

Hyeryun Kim is an author at Agios Pharmaceuticals (United States) specializing in medicine, health sciences, and cancer therapeutics.

Top concepts

MedicineHealthOncologyCancer TherapyRadiation OncologyPharmacologyCancer ResearchMolecular OncologyPathologyTumor Biology

Publications per year

2009–2021

26

Publications

26

Electrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis

Monika Bambousková, Laurent Gorvel, Vicky Lampropoulou et al. · Nature · 2018 · 695 citations · Full text

Inflammation, Cytokine, Inflammatory Disease +12

Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers

Janeta Popovici-Müller, René M. Lemieux, Erin Artin et al. · ACS Medicinal Chemistry Letters · 2018 · 422 citations · Full text

Idh1 Mutant Cancers, Somatic Point Mutations, Somatic Variant +14

Metabolic Profiling Using Stable Isotope Tracing Reveals Distinct Patterns of Glucose Utilization by Physiologically Activated CD8+ T Cells

H. Eric, Mark Verway, Radia Marie Johnson et al. · Immunity · 2019 · 395 citations · Full text

Metabolic Syndrome, Energy Metabolism, Systems Biology +15

Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages

Amanda Swain, Monika Bambousková, Hyeryun Kim et al. · Nature Metabolism · 2020 · 302 citations · Full text

Inflammation, Cytokine, Autoimmune Disease +11

Itaconate confers tolerance to late NLRP3 inflammasome activation

Monika Bambousková, Lucie Potůčková, Tomáš Paulenda et al. · Cell Reports · 2021 · 216 citations · Full text

Rows per page

1–5 of 26